The improvement in EF was pronounced in GRK5 Leu41 variants compared to Gln41 carriers and this observation coincided with another study reporting GRK5 polymorphism having a positive effect on systolic HF after β-blocker therapy [16]. This evidence concerns the gene GRK5 and hydrops fetalis.